News and developments

Drug Procurement GPOs: Antitrust Law Compliance Matters

Authors: Chen MA, Da SHI,
Junfeng CUI

The drug market in China has long been subject to both market competition and administrative control.
While the government leaves drug prices to market fundamentals in principle, it also actively
intervenes in the case of market failures, which includes adjusting the market structure to regulate
drug prices.

Read more...